| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | INGR | Common Stock | Options Exercise | $481K | +4.81K | +37.57% | $99.96 | 17.6K | Nov 29, 2024 | Direct | |
| transaction | INGR | Common Stock | Sale | -$705K | -4.81K | -27.31% | $146.69 | 12.8K | Nov 29, 2024 | Direct | F1 |
| transaction | INGR | Common Stock | Options Exercise | $1.44M | +12.1K | +94.49% | $118.97 | 24.9K | Nov 29, 2024 | Direct | |
| transaction | INGR | Common Stock | Sale | -$1.77M | -12.1K | -48.58% | $146.77 | 12.8K | Nov 29, 2024 | Direct | F2 |
| transaction | INGR | Common Stock | Options Exercise | $2.39M | +18.4K | +143.43% | $130.30 | 31.1K | Nov 29, 2024 | Direct | |
| transaction | INGR | Common Stock | Sale | -$2.69M | -18.4K | -58.92% | $146.78 | 12.8K | Nov 29, 2024 | Direct | F1 |
| transaction | INGR | Common Stock | Options Exercise | $1.8M | +19.6K | +153.34% | $91.85 | 32.4K | Nov 29, 2024 | Direct | |
| transaction | INGR | Common Stock | Sale | -$2.88M | -19.6K | -60.53% | $146.76 | 12.8K | Nov 29, 2024 | Direct | F1, F3 |
| holding | INGR | Common Stock | 30.1K | Nov 29, 2024 | Direct |
| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | INGR | Employee Stock Options (Right to Buy) | Options Exercise | $0 | -4.81K | -100% | $0.00 | 0 | Nov 29, 2024 | Common Stock | 4.81K | $99.96 | Direct | F4 |
| transaction | INGR | Employee Stock Options (Right to Buy) | Options Exercise | $0 | -12.1K | -100% | $0.00 | 0 | Nov 29, 2024 | Common Stock | 12.1K | $118.97 | Direct | F5 |
| transaction | INGR | Employee Stock Options (Right to Buy) | Options Exercise | $0 | -18.4K | -100% | $0.00 | 0 | Nov 29, 2024 | Common Stock | 18.4K | $130.30 | Direct | F6 |
| transaction | INGR | Employee Stock Options (Right to Buy) | Options Exercise | $0 | -19.6K | -100% | $0.00 | 0 | Nov 29, 2024 | Common Stock | 19.6K | $91.85 | Direct | F7 |
Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.
Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).
| Id | Content |
|---|---|
| F1 | The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $145.795 to $147.76, inclusive. The reporting person undertakes to provide full information as requested regarding the number of shares sold at each separate price. |
| F2 | The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $145.82 to $147.75, inclusive. The reporting person undertakes to provide full information as requested regarding the number of shares sold at each separate price. |
| F3 | Includes restricted stock units ("RSUs") acquired through deemed dividend reinvestment. RSUs acquired through deemed dividend reinvestment vest on the dates when the RSUs with respect to which they are deemed dividends vest. |
| F4 | These options vested in three equal annual installments on February 2, 2017, 2018 and 2019. |
| F5 | These options vested in three equal annual installments on February 7, 2018, 2019 and 2020. |
| F6 | These options vested in three equal annual installments on February 6, 2019, 2020 and 2021. |
| F7 | These options vested in three equal annual installments on February 8, 2020, 2021 and 2022. |
Amended to check the box to indicate that this transaction was made pursuant to a contract, instruction or written plan that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). This was inadvertently omitted in the original.